Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

Medicxi Closes New €400m Fund (Medicxi III) (2019-07-19)
> €400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b > Medicxi III will invest across the full healthcare continuum, from discovery to late stage clinical assets, empowering ambitiou...
AM-Pharma Raises €116m Round Led by LSP & Andera Partners (2019-07-16)
Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare Proceeds to be used for the 1,400-patient international piv...
Genmab & Blink Biomedical Enter Commercial License Agreement (2019-07-12)
Genmab and BliNK Biomedical have entered into a commercial license agreement to develop novel bispecific therapeutics based on BliNK Biomedical’s CD47 antibodies and Genmab’s DuoBody® Platform technology. Genmab A/S (Nasdaq Copenhagen: GEN) announced today tha...
Microphyt Raises €28.5m for Microalgae-based Solutions (2019-07-11)
> Microphyt secures one of the largest fundraising in the microalgae sector; > The round was co-led by Sofinnova Partners and Bpifrance (SPI Fund); > The funds will allow Microphyt to bring to market its range of natural products for nutrition and well-being ...
[iito] Launches Two New European Business Portals (2019-07-08)
> Brings Total of European Life Science Business Portals by [iito] to Six > Life-Sciences-UK.com & Life-Sciences-France.com Relaunched in April > Plans for Expansion of Coverage Beyond Europe > The »Tragedy of the Commons«, Revisited [iito] Business I...
Biophytis: $10.5m Global Offering including IPO at Nasdaq (2019-07-08)
Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics for age-related diseases, today announced its intention to offer and sell, subject to market and other conditi...
Oncovita Licenses Oncolytic Viruses from Institut Pasteur (2019-07-02)
Oncovita, a biotech company dedicated to the development of life-saving new treatments, in particular anti-cancer therapies, announces today that it has entered into a licensing agreement with Institut Pasteur, granting it an exclusive worldwide license to develop,...
[iito] Does Away with All Tracking and Third Party Cookies (2019-07-01)
> New Design of [iito] Web Portals Opens New Opportunities > High Quality Content Trumps the Collection of User Data > [iito] Life Sciences Business Portals Target Decision Makers Only > [iito] Portals on Course to Generate Several Millions of Page Views i...
Sanifit €55.2m Series D Round Led by Caixa Capital Risc (2019-06-26)
– Proceeds to enable progression of orphan designated lead candidate SNF472 into pivotal phase 3 trial for treatment of calciphylaxis – Round led by Spanish investor Caixa Capital Risc – Deal supported by new investors Columbus Venture Partners and Alta Life ...
Erytech Opens GMP Manufacturing Facility in Princeton, NJ (2019-06-24)
Inauguration event held last week to officially open 30,000 sq. ft GMP manufacturing facility constructed in Princeton, NJ to produce lead product candidate eryaspase in the United States ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biophar...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

Start here with the latest News!

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top